BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 28819535)

  • 41. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
    Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Al-Mughales JA
    Front Immunol; 2022; 13():850759. PubMed ID: 35359932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-nuscleosome antibody, a reliable indicator for lupus nephritis.
    Kiss E; Lakos G; Szegedi G; Poor G; Szodoray P
    Autoimmunity; 2009 Aug; 42(5):393-8. PubMed ID: 19811255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
    Quintana G; Coral-Alvarado P; Aroca G; Patarroyo PM; Chalem P; Iglesias-Gamarra A; Ruiz AI; Cervera R
    Autoimmun Rev; 2010 Sep; 9(11):750-5. PubMed ID: 20601199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.
    Vlachoyiannopoulos PG; Karassa FB; Karakostas KX; Drosos AA; Moutsopoulos HM
    Lupus; 1993 Oct; 2(5):303-12. PubMed ID: 8305923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations.
    Termaat RM; Brinkman K; Nossent JC; Swaak AJ; Smeenk RJ; Berden JH
    Clin Exp Immunol; 1990 Nov; 82(2):268-74. PubMed ID: 2242607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity.
    Chen D; Zhao L; Dai Y; Du F; Li E; Niu X; Wang Z; Zheng B; Lu L
    Front Immunol; 2022; 13():810639. PubMed ID: 35185903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature.
    Simmons SC; Smith ML; Chang-Miller A; Keddis MT
    Am J Nephrol; 2015; 42(6):451-9. PubMed ID: 26812129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital.
    El-Garf K; El-Garf A; Gheith R; Badran S; Salah S; Marzouk H; Farag Y; Khalifa I; Mostafa N
    Lupus; 2021 Feb; 30(2):211-218. PubMed ID: 33175664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco.
    Zian Z; Maamar M; Aouni ME; Barakat A; Naima Ghailani Nourouti ; El Aouad R; Arji N; Bennani Mechita M
    Biomed Res Int; 2018; 2018():3139404. PubMed ID: 30363993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.
    Pons-Estel GJ; Aspey LD; Bao G; Pons-Estel BA; Wojdyla D; Saurit V; Alvarellos A; Caeiro F; Haye Salinas MJ; Sato EI; Soriano ER; Costallat LT; Neira O; Iglesias-Gamarra A; Reyes-Llerena G; Cardiel MH; Acevedo-Vásquez EM; Chacón-Díaz R; Drenkard C
    Lupus; 2017 Jan; 26(1):73-83. PubMed ID: 27230554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study.
    Abid N; Khan AS; Al Otaibi FH
    Lupus; 2013 Dec; 22(14):1529-33. PubMed ID: 23934402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.